SEC Form 4 · accession 0000899243-16-015433
Baxalta Inc · BXLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Goff
Officer — EVP and President, Hematology
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001620546
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per shareF1 | Mar 3, 2016 | A | 35,605 | — | A | 68,938 | D | |
| Common Stock, par value $0.01 per shareF2 | Mar 3, 2016 | F | 1,338 | $39.30 | D | 67,600 | D | |
| Common Stock, par value $0.01 per shareF3 | Mar 4, 2016 | F | 303 | $39.47 | D | 67,297 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person received a grant of 35,605 restricted stock units which will vest in three equal installments beginning on the first anniversary of the grant date.
- F2Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 3, 2015.
- F3Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on March 4, 2014.